[Translation] A multicenter, randomized, open, parallel-group, positive-control study to evaluate the efficacy and safety of insulin aspart 30 injection combined with metformin in the treatment of type 2 diabetes that is poorly controlled by oral hypoglycemic drugs
主要目的: 比较门冬胰岛素30注射液与诺和锐®30分别与二甲双胍联合,治疗口服降糖药(OAD)血糖控制不佳的2型糖尿病患者的有效性; 次要目的: 比较门冬胰岛素30注射液与诺和锐®30分别与二甲双胍联合,治疗口服降糖药(OAD)血糖控制不佳的2型糖尿病患者的安全性。
[Translation] Primary objective: To compare the effectiveness of insulin aspart 30 injection and NovoRapid® 30 combined with metformin, in the treatment of patients with type 2 diabetes whose blood sugar is poorly controlled by oral hypoglycemic drugs (OADs); Secondary objective: To compare the safety of insulin aspart 30 injection and NovoRapid® 30 combined with metformin, in the treatment of patients with type 2 diabetes whose blood sugar is poorly controlled by oral hypoglycemic drugs (OADs).